Mediphar Labs. has launched DILO® gel in August 2018 in the Lebanese market.

DILO® gel is indicated for inflammation of the tendons, ligaments, muscles and joints, such as sprains, bruises, and strains, and for the short-term symptomatic treatment of acute pain in osteoarthritis.

We are proud to be introducing this medicament into the market, providing patients with a new topical treatment for pain. Dilo® gel provides all day relief from pain & swelling in joints and muscles by penetrating deep through the skin, relieving pain, and reducing inflammation directly at the source with favorable safety profile.

DILO® gel is available in the below dosage

• Diclofenac sodium, 2%, tube of 30 g


DILO® gel is reimbursed by local National Social Security Fund (NSSF).

Back to All News
We care about your questions and concerns. Please call the consumer healthcare service:
+961 4 540056 or by email: chs@medipharlabs.com